Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17001471 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Comparator: sitagliptin 100 mg;   Drug: Comparator: sitagliptin 200 mg;   Drug: Comparator: placebo;   Drug: Comparator: pioglitazone

Indicates status has not been verified in more than two years